DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Vogel A, Rimassa L, Sun H-C. et al.
Clinical value of atezolizumab + bevacizumab for first-line unresectable hepatocellular carcinoma (HCC): A network meta-analysis.
J Clin Oncol 2020;
38(15_suppl): 4585
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.